IBS-D
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed by Western medicine as IBS-D compliant; (2) Those who agree to undergo colonoscopy (those who have reported colonoscopy within the past 3 months may not undergo colonoscopy); (3) Those with IBS-SSS scale scores greater than 75; (4) Traditional Chinese medicine syndrome differentiation belongs to the syndrome of liver stagnation and spleen deficiency; (5) Those aged between 18 and 65; (6) Those who voluntarily participate and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Organic lesions and a history of abdominal surgery (such as cholecystectomy); (2) Patients with severe lesions in major organs such as the liver, brain, and kidneys, as well as patients with mental disorders; (3) Systemic diseases that affect gastrointestinal motility (such as hyperthyroidism, diabetes, chronic renal insufficiency, etc.); (4) Pregnant and lactating women; (5) Those who have used other drugs for the treatment of irritable bowel syndrome within the first week of screening; (6) Allergic constitution, as well as those who are allergic to known ingredients or any excipients of the study drug; (7) Suspected or with a history of alcohol or drug abuse; (8) Those who have participated in other clinical trials within three months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate calculated based on the degree of abdominal pain and abnormal bowel movements; | — |
Secondary
| Measure | Time frame |
|---|---|
| IBS-SSS scale;TCM syndrome efficiency evaluation;quality of life evaluation; | — |
Countries
China
Contacts
Dongfang Hospital Beijing University of Chinese Medicine